Halozyme Therapeutics Inc. logo

Halozyme Therapeutics Inc. (HALO)

Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
69. 82
+3.54
+5.34%
$
8.08B Market Cap
20.87 P/E Ratio
- Div Yield
2,144,457 Volume
2.74 Eps
$ 66.28
Previous Close
Add Transaction
Day Range
66 70.12
Year Range
51.06 82.22
Want to track HALO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Halozyme Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
MAF
MJT & Associates Financial Advisory Group Inc. MJT & Associates Financial Advisory Group Inc.
38 $2,787 $2,653.16 -$133.84 -4.8%
HIA
HFM Investment Advisors LLC HFM Investment Advisors LLC
25 $1,611.76 $1,745.5 $133.74 8.3%
WWL
Winnow Wealth LLC Winnow Wealth LLC
90 $6,120 $6,283.8 $163.8 2.68%
GWM
Gibbs Wealth Management Gibbs Wealth Management
3,101 $189,142.27 $216,511.82 $27,369.55 14.47%
BWL
Basepoint Wealth LLC Basepoint Wealth LLC
100 $6,730 $6,982 $252 3.74%
KMA
Kristy Michelle Afraimi BAM Wealth Management LLC
4,484 $289,801 $313,072.88 $23,271.88 8.03%